In October 2022, the Company released the Definitive Feasibility Study for its Cabinda Phosphate Project, which included estimates for the construction of a Beneficiation Plant. These estimates were again reviewed in July 2023 by the EPCM contractor. However, all construction projects have the risk of material cost rises, or construction delays that result in increased costs.
Any additional equity financing will dilute shareholdings, and additional debt financing, if available, may involve restrictions on financing and operating activities. If the Company is unable to obtain additional financing as needed, it may be required to reduce the scope of its operations and scale back its development programmes as the case may be. There is no guarantee that the Company will be able to secure any additional funding or be able to secure funding on terms favourable to the Company.
In October 2022, the Company released the Definitive Feasibility...
Add MNB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $48.44M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.7¢ | 5.4¢ | $45.22K | 832.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 291645 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 28404 | 3 |
View Market Depth
| Last trade - 14.58pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.7¢ | 5.4¢ | 247494 | ||
| Last updated 15.05pm 30/05/2024 ? | |||||
| MNB (ASX) Chart |